Table 5 Treatment and maternal and fetal outcomes

No transfusion

12 (36.36%)

Transfusion

21 (63.64%) (history of CS 14 cases)

Massive blood transfusion

10 (30.3%) (documentation 61.8% ~ 92.5% [5, 10])

Transfusion components

 erythrocytes

19 (57.58%)

 plasma

10 (30.3%)

 platelet

1 (3.03%)

 cold precipitation

7 (21.21%)

 autologous blood

2 (6.06%)

 Bleeding volume < 1000 ml

11 (33.33%)

  ≥ 1000 ml

22 (66.67%)(documentation 43.3 [11])

 1000 ~ 2000 ml

11 (33.33%)

  > 2000 ml

11 (33.33%)

 Hysterectomy (particular year)

7 (21.21%) (documentation 9.5% ~ 21.2% [2, 5])

 2015

5 (15.15%)

 2016

1 (3.03%)

 2017 ~ 2021

0

 2022

1 (3.03%)

 Total hysterectomy

5 (15.15%)

 Subtotal hysterectomy

2 (6.06%)

 Preoperative fetal death

13 (39.39%)

 Gestation week ≥ 28 weeks

8 (24.24%)

 Spontaneous contractions after fetal death

2 (6.06%)

 Perinatal deaths

15 (45.45%) (documentation 26.2% ~ 83.6% [12, 13])

 Fetal malformation induced labor

3 (9.09%)

 Neonatal severe asphyxia

2 (6.06%, full-term gestation) (documentation 25.2 [5])

 Maternal death

1 (3.03%) (documentation 1.2% ~ 15.9% [2, 14])